560 related articles for article (PubMed ID: 18977268)
21. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
22. Pattern of pre-existing IgG subclass responses to a panel of asexual stage malaria antigens reported during the lengthy dry season in Daraweesh, Sudan.
Nasr A; Iriemenam NC; Troye-Blomberg M; Arnot D; Theander TG; Berzins K; Giha HA; Elghazali G
Scand J Immunol; 2011 Oct; 74(4):390-6. PubMed ID: 21645028
[TBL] [Abstract][Full Text] [Related]
23. Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure.
Perraut R; Marrama L; Diouf B; Fontenille D; Tall A; Sokhna C; Trape JF; Garraud O; Mercereau-Puijalon O
J Infect Dis; 2003 Dec; 188(12):1940-50. PubMed ID: 14673775
[TBL] [Abstract][Full Text] [Related]
24. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
26. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children.
Okech B; Mujuzi G; Ogwal A; Shirai H; Horii T; Egwang TG
Am J Trop Med Hyg; 2006 Feb; 74(2):191-7. PubMed ID: 16474069
[TBL] [Abstract][Full Text] [Related]
27. Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection.
Meraldi V; Nebié I; Tiono AB; Diallo D; Sanogo E; Theisen M; Druilhe P; Corradin G; Moret R; Sirima BS
Parasite Immunol; 2004; 26(6-7):265-72. PubMed ID: 15541030
[TBL] [Abstract][Full Text] [Related]
28. [Specific antibodies to Plasmodium falciparum antigens in immune patients: IV--Cross-sectional analysis of anti-P. falciparum Ab responses in a mesoendemic zone of transmission in Sine-Saloum region].
Sidibé S; Diouf B; Tall A; Spiegel A; Trape JF; Garraud O; Dièye A; Perraut P
Dakar Med; 2000; 45(2):117-21. PubMed ID: 15779164
[TBL] [Abstract][Full Text] [Related]
29. IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine.
Quelhas D; Jiménez A; Quintó L; Serra-Casas E; Mayor A; Cisteró P; Puyol L; Wilson DW; Richards JS; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Aponte JJ; Alonso PL; Beeson JG; Menéndez C; Dobaño C
Immunobiology; 2011 Jul; 216(7):793-802. PubMed ID: 21257227
[TBL] [Abstract][Full Text] [Related]
30. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria.
Courtin D; Djilali-Saïah A; Milet J; Soulard V; Gaye O; Migot-Nabias F; Sauerwein R; Garcia A; Luty AJ
Parasite Immunol; 2011 Feb; 33(2):124-31. PubMed ID: 21226725
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
Agak GW; Bejon P; Fegan G; Gicheru N; Villard V; Kajava AV; Marsh K; Corradin G
Vaccine; 2008 Apr; 26(16):1963-71. PubMed ID: 18342997
[TBL] [Abstract][Full Text] [Related]
32. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria.
Leoratti FM; Durlacher RR; Lacerda MV; Alecrim MG; Ferreira AW; Sanchez MC; Moraes SL
Malar J; 2008 Sep; 7():186. PubMed ID: 18816374
[TBL] [Abstract][Full Text] [Related]
33. Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum.
Naus CW; Jones FM; Satti MZ; Joseph S; Riley EM; Kimani G; Mwatha JK; Kariuki CH; Ouma JH; Kabatereine NB; Vennervald BJ; Dunne DW
J Infect Dis; 2003 Apr; 187(8):1272-82. PubMed ID: 12696007
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
35. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
[TBL] [Abstract][Full Text] [Related]
36. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.
Scopel KK; da Silva-Nunes M; Malafronte RS; Braga EM; Ferreira MU
Am J Trop Med Hyg; 2007 Jun; 76(6):1084-91. PubMed ID: 17556615
[TBL] [Abstract][Full Text] [Related]
37. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
38. [Antibodies specific to Plasmodium falciparum antigens in immune individuals: III. Seasonal course of the response to a major antigen of the asexual blood forms in two sites of different malaria exposure].
Diallo TO; Nguer CM; Tall A; Diouf A; Spiegel A; Perraut R; Garraud O
Dakar Med; 1999; 44(1):63-8. PubMed ID: 10797990
[TBL] [Abstract][Full Text] [Related]
39. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
[TBL] [Abstract][Full Text] [Related]
40. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.
Ahmed Ismail H; Tijani MK; Langer C; Reiling L; White MT; Beeson JG; Wahlgren M; Nwuba R; Persson KE
Malar J; 2014 Nov; 13():425. PubMed ID: 25373511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
